Literature DB >> 21934096

CTLA-4: not all costimulation is stimulatory.

Hugh Auchincloss1, Laurence A Turka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21934096      PMCID： PMC3178888          DOI： 10.4049/jimmunol.1102316

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  13 in total

Review 1.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

3.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid.

Authors:  L E Samelson; R N Germain; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

Review 4.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept.

Authors:  K J Lafferty; S J Prowse; C J Simeonovic; H S Warren
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

Review 5.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

6.  A theory of self-nonself discrimination.

Authors:  P Bretscher; M Cohn
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

Review 7.  Mechanisms of costimulation.

Authors:  Arlene H Sharpe
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

8.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

9.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

Authors:  P S Linsley; J L Greene; P Tan; J Bradshaw; J A Ledbetter; C Anasetti; N K Damle
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).

Authors:  T Hara; S M Fu; J A Hansen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307
View more
  5 in total

Review 1.  Immunotherapies for bladder cancer: a new hope.

Authors:  Farhad Fakhrejahani; Yusuke Tomita; Agnes Maj-Hes; Jane B Trepel; Maria De Santis; Andrea B Apolo
Journal:  Curr Opin Urol       Date:  2015-11       Impact factor: 2.309

2.  [Association between CTLA-4 gene polymorphism and Henoch-Schönlein purpura in children].

Authors:  Hong-Hong Hou; Yan-Ping Huang; Li Liu; Gai-Tao He
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-03

3.  Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation.

Authors:  D V Chan; H M Gibson; B M Aufiero; A J Wilson; M S Hafner; Q-S Mi; H K Wong
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

4.  High CD45 expression of CD8+ and CD4+ T cells correlates with the size of HIV-1 reservoir in blood.

Authors:  Stefan Petkov; Yonas Bekele; Tadepally Lakshmikanth; Bo Hejdeman; Maurizio Zazzi; Petter Brodin; Francesca Chiodi
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

5.  Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.

Authors:  Lin-Lin Ye; Wen-Bei Peng; Yi-Ran Niu; Xuan Xiang; Xiao-Shan Wei; Zi-Hao Wang; Xu Wang; Si-Yu Zhang; Xin Chen; Qiong Zhou
Journal:  Ann Transl Med       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.